Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line

MADISON, Wis., Nov. 18, 2010 /PRNewswire/ -- Forte Research Systems, makers of OnCore® , the most widely adopted clinical research platform among academic research organizations and cancer centers in the United States, unveiled a new product line today, the Allegro™ Research on Demand, cloud-based clinical research management solution. The first product in the new line is Allegro CTMS@Site™, the clinical trials management system built exclusively for investigational sites.

(Photo: http://photos.prnewswire.com/prnh/20101118/CG04162)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101118/CG04162)

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101115/CG02078LOGO)

Research coming out of Tufts Center for the Study Drug Development shows that over half of the clinical research being conducted worldwide is taking place in physician practices, community hospitals, and dedicated research sites. These relatively small sites are experiencing trends in the industry in ways that are distinct from large research organizations.

"Trends in the industry are creating a significant increase in administrative overhead and regulatory exposure for the sites," said Srini Kalluri, founder, president & CEO of Forte Research Systems. "We built Allegro CTMS@Site to address these specific challenges from the sites' perspective."

Pharmaceutical companies conducting clinical trials on new drugs are spreading the work among more sites as a way to increase the probability of success and to reach more potential patient participants. In turn, this trend has led individual sites to take on more trials. At the same time, while sites are grappling with more trials, the trials are becoming much more complex with a proliferation of procedures and subject eligibility criteria.

In an attempt to be more competitive and efficient in this environment, today's sites are implementing tighter financial management, overseeing regulatory compliance more intensively, striving to achieve status as a preferred partner, and adopting clinical trials management systems (CTMS) to streamline operations and replace paper-based processes.

"When it comes to CTMS, current solutions in the marketplace leave a lot to be desired," said Kalluri.

With what is currently available, sites have to choose between products with bloated functionality and complex interfaces that require up-front investments in infrastructure, have ongoing maintenance and administrative overhead, and have long training cycles with slow user adoption rates.

By contrast, the Allegro product line is built for clinical research operations excellence with no software to install and no systems administration required, real-time visibility into the entire clinical research portfolio, and a user-centric, intuitive interface that is easy to use, virtually eliminating the need for training. With Allegro CTMS@Site, sites can get up and running in a single day.

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers.

PercipEnz Technologies is now Forte Research Systems. Same company, new name.

SOURCE Forte Research Systems